← Eichor
Study identifier: NCT05064124 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Early DiAgnosis Real-Time Healthcare System for CANcer Trial

Condition: Polyps · Adenoma Colon · Colorectal Polyp  ·  Sponsor: University College, London

PhaseN/A
Planned participants420
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The purpose of the study is to assess whether the AI characterisation system of the CADDIE device improves the endoscopists accuracy in the optical diagnosis of diminutive colorectal polyps in the bowel during colonoscopy. Participants will either have a colonoscopy with the assistance of the CADDIE device characterisation AI system ("intervention group") or have a colonoscopy in line with routine clinical practice i.e., without the CADDIE device characterisation AI system ("control group"). The randomisation method of this trial will allocate enrolled participants to the "intervention" group and to the "control" group by a technique similar to flipping a coin.

This description comes directly from the study's public registry record.

Talk to the study team

Sharon Cheung, MSc  ·  02076795217  ·  sharon.cheung@ucl.ac.uk

Rawen Kader, MBBS MRCP  ·  02076795217  ·  rawen.kader.17@ucl.ac.uk

Always discuss trial participation with your own doctor first.

Locations (1)

University College London Hospitals NHS Foundation TrustLondon, United KingdomRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05064124